[The efficacy of heparin therapy in patients with diabetic glomerulosclerosis].
Heparin therapy (25,000 U/day) of 38 patients with diabetic glomerulosclerosis resulted in improvement in 31 (82 +/- 6%). The treatment was not effective in 5% and complications were seen in 2 patients. Blood coagulation control is necessary during heparin treatment and turbidimetry proved to be highly informative in objective registration of coagulation and fibrinolysis processes.
Pyrih
L A
LA
Lapchyns'ka
I I
II
Belyts'ka
H O
HO
Lezhen
T I
TI
D000328:Adult; D001780:Blood Coagulation Tests; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications; D003928:Diabetic Nephropathies / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000097:blood / Q000188:drug therapy*; D006487:Hemostasis / Q000187:drug effects; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D013997:Time Factors
D006493:Heparin
Efektyvnist' heparynoterapiï khvorykh na diabetychnyĭ hlomeruloskleroz.